Medical News

RSS

New study suggests potential treatment for blindsight patients

Although we assume we can see everything in our field of vision, the brain actually picks and chooses the stimuli that come into our consciousness. A new study in the Association for Research in Vision and Ophthalmology's Journal of Vision reveals that our brains can be trained to consciously see stimuli that would normally be invisible.

22 Oct 2009

CHOP implements InforSense-based Translational Research Solution to study complex genetic disease

IDBS, the leading worldwide provider of research data management and analytics solutions to R&D organizations, today announced that The Children's Hospital of Philadelphia (CHOP), one of the leading pediatric hospitals and research facilities in the world, has implemented the InforSense-based Translational Research Solution to advance the understanding of complex genetic disease.

22 Oct 2009

Halozyme Therapeutics commences patient dosing in Phase 3 Enhanze trial with Herceptin

Halozyme Therapeutics, Inc. and Roche today announced dosing of the first patient in a Phase 3 registration trial using Enhanze™ technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation with Roche’s anticancer biologic, Herceptin (trastuzumab).

22 Oct 2009

Nationwide Better Health launches workplace benefit plans for employees

Nationwide Better HealthSM recently announced the launch of its workplace benefits for employees including accident and hospital products, group dental plans, group term life insurance and medical stop loss insurance. These offerings allow employers to provide benefits that help safeguard their employees’ physical and financial health.

22 Oct 2009

OSI Pharmaceuticals reports total revenues of $111 million for the third quarter of 2009

OSI Pharmaceuticals, Inc. announced today its financial results for the Company’s third quarter ended September 30, 2009. The Company reported total revenues from continuing operations of $111 million for the third quarter of 2009 compared to revenues of $95 million for the third quarter of 2008, an 18% increase over the prior year period.

22 Oct 2009

Grand Challenges Explorations grant for Seventh Sense Biosystems

Seventh Sense Biosystems announced today that it has received a Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Dr. Howard Bernstein, titled “On-skin and Intra-dermal Malaria Diagnostics with Unprecedented Simplicity of Use Based on Bio-Responsive Particles and Interstitial Fluid Analysis.”

22 Oct 2009

Illumina announces 2010 roadmap for Infinium whole-genome genotyping platform

At the 59th annual meeting of the American Society of Human Genetics, Illumina, Inc. today announced its 2010 roadmap for the Infinium whole-genome genotyping platform, offering products capable of analyzing up to five million (5M) variants per sample.

From Illumina, Inc. 22 Oct 2009

CDC urges heart disease patients get vaccinated against the flu each year

Cardiovascular disease was the leading cause of death in Florida in 2005, accounting for approximately 35 percent of all deaths in the state. People with heart disease are at a high risk for serious and potentially life-threatening complications from the flu.

22 Oct 2009

Dr. John Kitzhaber on reforming health care

Kaiser Health News features an interview with former Oregon governor, Dr. John Kitzhaber. When he "was president of the Oregon Senate, the state's languishing economy was tightening the screws on Medicaid outlays.

22 Oct 2009

Essilor International announces its third-quarter report

Essilor International, the world leader in ophthalmic optics, today announced its consolidated revenue for the nine months ended September 30, 2009.

22 Oct 2009

Study results of PTH1-34 oral parathyroid hormone presented

Emisphere Technologies, Inc. today announced study results demonstrating that a single dose of the novel oral parathyroid hormone PTH1-34, which utilizes Emisphere’s proprietary Eligen® Drug Delivery Technology and absorption-enhancer carrier molecule 5-CNAC, achieved potentially therapeutically relevant exposure and safety profiles to those of the currently available injectable formulation in healthy postmenopausal women.

22 Oct 2009

Fluorescent molecule to detect cyanide contamination in drinking water

A small molecule designed to detect cyanide in water samples works quickly, is easy to use, and glows under ultraviolet or "black" light.

22 Oct 2009

Budget hawks block Reid's push for 'doc fix'

Democrats backed away from an unfunded proposal to increase physician payments from Medicare in the face of opposition from Republicans and some fiscally conservative members of their own ranks, the New York Times reports.

22 Oct 2009

TomoTherapy adds the TomoHD treatment system to its suite of advanced radiation therapy solutions

TomoTherapy Incorporated today announced that it has extended its suite of advanced radiation therapy solutions with the addition of the TomoHD™ treatment system, an efficient, all-purpose new system designed to make it easier for any radiation oncology department to adopt TomoTherapy® technology for its patient population.

22 Oct 2009

Study compares effects of clin-BPO 2.5% and clin-BPO 5% on epidermal functions

Dermatologists agree that topical fixed-combination products containing clindamycin (clin) and benzoyl peroxide (BPO) are effective in the treatment of acne. However, products containing BPO concentrations at 5% or higher may limit use due to associated dryness and irritation in some patients.

22 Oct 2009

Enrollment in medical school rises slightly as physician demand also increases

New figures show that enrollment in medical school continues to rise as schools try to increase the number of graduates to meet the increasing physician need. But doctors cautioned that more residency positions are needed and urged federal officials to fund them.

22 Oct 2009

Constant light at night can increase depressive symptoms

Researchers found that mice housed in a lighted room 24 hours a day exhibited more depressive symptoms than did similar mice that had a normal light-dark cycle.

22 Oct 2009

NicOx reports financial results for the first nine months of 2009

NicOx S.A. today reported financial results for the nine months ended September 30, 2009.

22 Oct 2009

AHF commends Congress for its passage of the Ryan White CARE Act

AIDS Healthcare Foundation (AHF), the largest global AIDS organization which provides services to more than 129,000 people in the US, Africa, Latin America/Caribbean and Asia, today commended Congress for its passage of the Ryan White CARE Act (RWCA, or the CARE Act), the federal law that provides the primary source of funding for AIDS care and services nationwide. The bill cleared the Senate on Monday by unanimous consent and passed the House earlier today by a 408 to 9 vote.

22 Oct 2009

New findings from ADVANCE clinical trial presented

New analyses of the largest-ever clinical trial of patients with type 2 diabetes show that the combination of blood pressure lowering treatment and intensive glucose (blood sugar) control improved patients' vascular condition and resulted in a significant 18 percent reduction in the risk of death from all causes.

22 Oct 2009